BioSante grants Aduro exclusive, worldwide rights to BioSante's GVAX cancer vaccines for use in combination with Aduro's Listeria monocytogenes bacterial vectors

BioSante Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Aduro Biotech Inc.

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced